Home > Specialties > IVD Test Reagent/Kits, Immunoassay, Autoimmune, Antineutrophil Cytoplasmic Antibody, Proteinase 3

IVD Test Reagent/Kits, Immunoassay, Autoimmune, Antineutrophil Cytoplasmic Antibody, Proteinase 3

Definition : Immunoassay reagents intended to perform qualitative and/or quantitative analyses on a body fluid sample (e.g., serum) to determine antineutrophil cytoplasmic antibodies to proteinase 3 (PR3-ANCA). Increased circulating levels of PR3-ANCA are used in the diagnostic of systemic vasculitis, they are also associated with extra-renal organ involvement (especially respiratory involvements), autoimmune connective tissue diseases, and Wegener's granulomatosis. Most patients identified with cytoplasmic-ANCA using indirect immunofluorescence, a less specific method, have antibodies to PR3-ANCA.

Entry Terms : "Proteinase 3 Antineutrophil Cytoplasmic Antibody (PR3-ANCA) Determination Reagents" , "Proteinase 3 (PR3) Determination Reagents" , "PR3-ANCA Determination Reagents" , "PR3-ANCA (Proteinase 3 Antineutrophil Cytoplasmic Antibody) Determination Reagents" , "Reagents, Immunoassay, Autoimmune, Antineutrophil Cytoplasmic Antibody, Proteinase 3"

UMDC code : 20113

Filters
Manufacturers
Distributors
U.S.companies only
Suppress Subsidiary Companies
   

1-4 of 4 Match(es).

Bioline USA Inc

Company Type: Parent

Hemagen Diagnostics Inc

Company Type: Parent

Hemagen Inc. was founded in 1985 by a group of scientists from the Boston University School of Medicine.

Mayo Medical Laboratories

Company Type: Parent

Zeus Scientific Inc

Company Type: Parent

ZEUS Scientific is a privately held corporation that was founded in 1976. The company began producing IFA (immunofluorescence assay) test systems followed ELISA and now multiplex (AtheNA Multi-Lyte) immunoassays. New products are developed to expand the menu which allows laboratories to run an increasing number of assays with common protocols and common reagents, as well as developing new tests to more accurately diagnose patients. In 1987 ZEUS Scientific was the first company to develop, receive appropriate regulatory clearance and bring to market a serological assay to test for Lyme disease – a condition with high prevalence in the local community where ZEUS Scientific is located.

1-4 of 4 Match(es).